Filing Details
- Accession Number:
- 0001209191-17-067075
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-12-22 16:32:47
- Reporting Period:
- 2017-12-20
- Accepted Time:
- 2017-12-22 16:32:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 921299 | Fibrogen Inc | FGEN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1623238 | B Thomas Neff | C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158 | Chief Executive Officer | Yes | Yes | No | No |
Transaction Summary
| Sold: | 38,636 shares | Avg. Price: $44.66 | Total Value: $1,725,654.45 |
| Number of Shares After Transactions: | 127,514 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-12-20 | 7,071 | $43.66 | 3,022,934 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-20 | 11,829 | $44.39 | 3,011,105 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-20 | 418 | $43.64 | 127,932 | No | 4 | S | Indirect | By Family Partnership |
| Common Stock | Acquisiton | 2017-12-21 | 24,541 | $3.60 | 3,035,646 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-21 | 36,735 | $2.90 | 3,072,381 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2017-12-21 | 18,724 | $3.50 | 3,091,105 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-12-21 | 9,377 | $44.92 | 3,081,728 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-21 | 9,523 | $45.52 | 3,072,205 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-12-21 | 418 | $45.22 | 127,514 | No | 4 | S | Indirect | By Family Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Family Partnership |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By Family Partnership |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-21 | 24,541 | $0.00 | 24,541 | $3.60 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-21 | 36,735 | $0.00 | 36,735 | $2.90 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2017-12-21 | 18,724 | $0.00 | 18,724 | $3.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2019-03-11 | No | 4 | M | Direct | |
| 0 | 2020-06-09 | No | 4 | M | Direct | |
| 32,870 | 2021-06-07 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 20,000 | Indirect | By Spouse |
| Common Stock | 60,946 | Indirect | See footnote |
Footnotes
- Shares sold pursuant to a 10b5-1 plan.
- The shares were sold at prices ranging from $43.15 to $44.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $44.15 to $44.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $43.35 to $44.35. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $44.35 to $45.325. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $45.35 to $45.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares were sold at prices ranging from $45.10 to $45.40. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- The shares are held by BioGrowth Partners, LP. The reporting person is the sole general partner of BioGrowth Partners, LP and has sole voting and dispositive power over the shares held by BioGrowth Partners, LP.
- Fully vested.
Billionaire Hedge Funds
